Observational study of different dose of S-Ketamine combined with propofol during endoscopy in children with different ages

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042704

Enrollment

Unknown

Registered

2021-01-26

Start date

2021-02-02

Completion date

Unknown

Last updated

2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring gastroscopy in children

Interventions

PS1 Group:only propofol used

PS2 Group:propofol used followed by 0.3mg.kg S-Katemine used

PS3 Group:propofol used followed by 0.4mg.kg S-Katemine used

PS4 Group:propofol used followed by 0.5mg.kg S-Katemine used

AS1 Group:only propofol ued

AS2 Group:propofol used followed by 0.3mg.kg S-Katemine used

AS3 Group:propofol used followed by 0.4mg.kg S-Katemine used

AS4 Group:propofol used followed by 0.5mg.kg S-Katemine used

Eligibility

Sex/Gender

All

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 1-12 years old; 2. Children with ASA (American Society of Anesthesiology) preoperative comprehensive condition grade <= II; 3. Children without abnormal airway; 4. Those children without high risk of reflux aspiration due to anatomical abnormalities and mechanical obstruction of digestive tract.

Exclusion criteria

Exclusion criteria: 1. Children with progressive gastric bleeding; 2. Obese children (BMI > 35kg / m2).

Design outcomes

Primary

Measure	Time frame
success rate of smooth endoscope insertion;	—

Secondary

Measure	Time frame
total doses of proppfol be used every group;recovery time;adverse events;	—

Countries

China

Contacts

Public ContactZhang Bin

Qilu Children's Hospital of Shandong University

qletyymzk@sina.com+86 18866115706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026